-
After a heart attack, beta-blockers are often a lifelong medicine. Maybe they shouldn’t be for stable low-risk post-MI patients
Medical Mythbusting Commentary for March 31, 2026 Source:After a heart attack, beta-blockers are often a lifelong medicine. Maybe they shouldn’t be
-
House Calls, #1008, March 29, 2026: I’ll risk a hazard!
When trying to determine the risk to health from various products and foods, there are specific measures and definitions that are used to help understand the true real-life risks. These are exemplified and explained by Dr. Joe Schwarz in his article using the weed killer glyphosate as an example. Your Calls and Comments: Playlist 1st…
-
Highly Mutated New COVID Variant ‘Cicada’ Detected in 25 U.S. States. Levels Are Currently Very Low.
Medical Mythbusting Commentary for March 27, 2026 Source:Highly Mutated New COVID Variant ‘Cicada’ Detected in 25 U.S. States
-
The reason Vitamin K1 is given to newborns and why it has been a standard of care for over 65 years.
Medical Mythbusting Commentary for March 26, 2026 Source:It’s not just vaccines: Parents are refusing other routine preventive care for newborns
-
It stands to reason that most medications designed to manage progressive chronic disease once discontinued will see a relapse or progression of said disease process.
Medical Mythbusting Commentary for March 25, 2026 Source:Stopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds Reference:GLP-1RA discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: A target emulation trial.
-
Welcome to allergy season. Here’s how to protect yourself
Medical Mythbusting Commentary for March 24, 2026 Source:Welcome to allergy season. Here’s how to protect yourself
-
New Pancreatic Cancer Treatment Wipes Out Tumors and Blocks Drug Resistance in Mouse Model. Human Trials Pending
Medical Mythbusting Commentary for March 20, 2026 Source:New Pancreatic Cancer Treatment Wipes Out Tumors and Blocks Drug Resistance Reference:A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance